|
LT-Ivax
Fowl laryngotracheitis virus, strain LT-IVAX >/= 10^2.9 TCID50 per dose of 0.03 ml IU/ml
|
Freeze dried pellet for injection after reconstitution
>/= 10^2.9 TCID50 per dose of 0.03 ml IU/ml
|
Zambia
|
ZAMRA-VM-26-97
|
Registered/Compliant
|
|
M+PAC
Mycoplasma hyopneumonia 1 ml
|
Emulsion for injection
1 ml
|
Zambia
|
ZAMRA-VM-26-34
|
Registered/Compliant
|
|
MASTIPLAN LC
None
|
-
|
South Africa
|
09/16.1/17
|
Registered
|
|
MESALIN
None
|
-
|
South Africa
|
98/22.6.1/3
|
Canceled
|
|
MOMETAMAX
None
|
-
|
South Africa
|
19/14.3/26
|
Registered
|
|
MOMETAMAX FORTE
Gentamicin sulfate equivalent to gentamicin; Posaconazole; Mometasone furoate monohydrate equivalent to mometasone
|
-
|
South Africa
|
23/14.3/05
|
Registered
|
|
Mastijet® Forte
Bacitracin 2000 IU,Neomycin base (as sulphate) 250 mg,Prednisolone 10 mg,Tetracycline Hydrochloride 200 mg
|
Suspension for Injection
10 mg,200 mg,2000 IU,250 mg
|
Zambia
|
331/710V
|
Registered/Compliant
|
|
Multivax P
Clostridium perfringens type D, Clostridium septicum, Clostridium tetani as well as purified killed cultures of Clostridium chauvoei, and antigens from Pasteurella haemolytica serotypes A1, A Cl. Perfringens type D-58-116 TCP units, Cl. Tetan Units
|
Injection
Cl. Perfringens type D-58-116 TCP units, Cl. Tetan Units
|
Zambia
|
ZAMRA-VM-26-417
|
Registered/Compliant
|
|
Multivax P Plus
C. chauvoei Toxoid 6-12 mg/gm,C. novyi type B toxoid Toxoid 8-160 mg/gm,C. perfringens type C toxoid Toxoid 30-60 mg/gm,C. perfringens type D toxoid Toxoid 80-160 mg/gm,C. septicum toxoid Toxoid 3-6 mg/gm,C. tetani toxoid Toxoid 6-12 mg/gm,Mannheimia haemolytica Strain NL 1009 5x10^5 mg/gm
|
Liquid for injection
5x10^5 mg/gm,Toxoid 3-6 mg/gm,Toxoid 30-60 mg/gm,Toxoid 6-12 mg/gm,Toxoid 8-160 mg/gm,Toxoid 80-160 mg/gm
|
Zambia
|
ZAMRA-VM-26-26
|
Registered/Compliant
|
|
NOBILIS REO INAC
Reo strain and 2408 7.4 log2 ELISA units Units,Reovirus strain #1733 virus bearing fluids 7.4 log2 ELISA units Units
|
Suspension for Injection
7.4 log2 ELISA units Units
|
Zambia
|
ZAMRA-VM-26-445
|
Registered/Compliant
|
|
NOBILIS® IB+ND VACCINE
Inactivated infectious bronchitis virus Massachussetts type 6log2HI Units,Inactivated Newcastle Disease Virus 50 PD50 Units
|
Water in oil emulsion
50 PD50 Units,6log2HI Units
|
Zambia
|
331/720V
|
Registered/Compliant
|
|
NOBIVAC RABIES VACCINE
2% AlPO4 0,15 ml,Maintenance medium 0,8 ml,Na2HPO4.2H2O 5 mg/6 mL,NaH2PO4.2H2O 0,9 mg/6 mL,Purified Water. 0,05 ml,Rabies virus inactivated antigen suspension > 0.95 AIU* equivalent to>2.0 IU,Thiomersal 0,01 – 0,02 %
|
Suspension for injection
0.95
|
Tanzania
|
TAN 24 V 0392
|
Registered/Compliant
|
|
NUFLOR INJECTION
None
|
-
|
South Africa
|
96/21.1/1
|
Registered
|
|
NUFLOR MINIDOSE
FLORFENICOL
|
-
|
South Africa
|
10/17.1/05
|
Registered
|
|
NUFLOR SWINE PREMIX
None
|
-
|
South Africa
|
07/17.1/12
|
Registered
|
|
NUMELVI 21,6 mg TABLETS
ATINVICITINIB
|
-
|
South Africa
|
25/13/03
|
Registered
|
|
NUMELVI 31,6 mg TABLETS
ATINVICITINIB
|
-
|
South Africa
|
25/13/04
|
Registered
|
|
NUMELVI 4,8 mg TABLETS
ATINVICITINIB
|
-
|
South Africa
|
25/13/01
|
Registered
|
|
NUMELVI 7,2 mg TABLETS
ATINVICITINIB
|
-
|
South Africa
|
25/13/02
|
Registered
|
|
Nobilis CAVP4 Vaccine
-
|
Suspension for Injection
|
Zambia
|
ZAMRA-VM-26-437
|
Registered/Compliant
|